We determined the association of lower-body fat mass (LFM) and trunk fat mass (TFM) with cardiometabolic risk factors and adipokines in young, healthy, slim women. Methods: A total of 481 college female students underwent the following: regional body fat distribution as assessed by dual energy X-ray absorptiometry (DXA), a 75g oral glucose tolerance test (OGTT) and fasting blood sampling for measurement of lipids, lipoproteins, apolipoproteins (apo), liver enzymes and adipokines. Results: After adjusting for TFM, LFM was positively associated with HDL cholesterol, adiponectin, pre-heparin lipoprotein lipase and insulin sensitivity, as estimated by the Matsuda index, whereas it was negatively related to triglycerides, apo B, apo B/A1 ratio, small dense LDL, FFA, glucose and insulin at 2h during OGTT, area under the curve of insulin response during OGTT and the white blood cell count. Participants were divided into 9 groups according to tertiles of TFM and LFM. In the middle tertile of TFM, HDL cholesterol and adiponectin increased and triglycerides, apoB/A1 ratio and plasminogen-activator inhibitor-1 decreased from the low to high LFM tertiles. Gammaglutamyltransferase levels in middle and high LFM tertiles were lower than in the lower LFM tertile. Conclusion: For a given level of trunk fat mass, a higher lower-body fat mass is associated with an advantageous profile of not only blood lipoproteins but also serum adipokines, even in healthy, slim women in early adulthood. J Atheroscler Thromb, 2011; 18:365-372.
tions [4] [5] [6] [7] [8] . Studies in postmenopausal women have revealed that trunk fat mass (TFM) measured using dual energy X-ray absorptiometry (DXA) is a strong independent predictor of insulin resistance and dyslipidemia [9] [10] [11] [12] . Several studies have also suggested that in contrast with trunk fat, peripheral adiposity may attenuate both insulin resistance and dyslipidemia [10] [11] [12] [13] [14] [15] or just lipid levels 16) in normal and overweight postmenopausal women. Although these differences may be due to differences in adipokine secretion from regional adipose tissue, a few studies have determined serum adipokine levels 17, 18) . The majority of the above studies using DXA have been limited to females with a mean BMI of
Introduction
Increases in abdominal circumference have been demonstrated to be associated with an increased risk of both cardiovascular diseases and type 2 diabetes [1] [2] [3] . On the other hand, increases in hip circumference seem to have protective effects against these condi-around 26 kg/m 2 , but have also included senior subjects. Because obesity and ageing are known to affect glucose and lipid metabolism, specifically in women 19) , and because very little information is available on the relationship between regional body composition and cardiovascular risk factors in very young and lean adults, we studied healthy, very young and slim women as described below to avoid confounding factors. The aim of this study was first whether fat mass is associated with numerous cardiometabolic risk factors and adipokines in healthy, slim women in early adult life with a narrow age span. A second aim was to investigate the association between regional fat mass by DXA and risk factors and adipokines.
Subjects and Methods

Participants
481 female students at Mukogawa Women's University were enrolled; all were Japanese and aged 18-24 years. Subjects with clinically diagnosed acute or chronic inflammatory diseases, endocrine, cardiovascular, hepatic, renal diseases, hormonal contraception, or unusual dietary habits were excluded. No subject was taking any medication. The study was approved by the ethics committees of the university and written informed consent was obtained from all participants.
Anthropometry and Body Composition
Body weight, height, and waist circumference (WC) were measured following standard procedures and BMI was calculated. Whole-body DXA was performed using fan beam technology (Hologic QDR-2000, software version 7.20D; Waltham, MA). This software provides estimates of lean tissue mass, fat mass, and bone mineral mass for the total body and for standard body regions. Using specific anatomic landmarks, regions of the head, trunk, arms, and legs were distinguished as previously reported 20) .
Insulin, Glucose, and Insulin Resistance
Blood samples were obtained in the morning after a 12-hr overnight fast. The oral glucose tolerance test (OGTT) was performed with 75-g glucose administration in 165 participants. Blood samples were taken at 0, 30, 60, and 120 min for glucose and insulin analysis. Plasma glucose was determined by the hexokinase/glucose-6-phosphate dehydrogenase method [interassay coefficient of variation (CV) 2%]. Serum insulin was measured by ELISA with narrow specificity, excluding des-31, des-32, and intact proinsulin (interassay CV 6%). Insulin resistance was determined by homeostasis model assessment (HOMA-IR) using fasting plasma glucose and insulin levels 21 ) and Matsuda's index (insulin sensitive index, ISI) using glucose and insulin levels during OGTT 22) . Area under the curve during OGTT (AUC) was calculated using the trapezoidal method.
Lipids, Lipoproteins, Apolipoproteins and Liver Enzymes
Serum triglycerides, total cholesterol, high-density lipoprotein (HDL) cholesterol and liver enzymes were measured in fasted blood samples using an autoanalyzer (AU5232; Olympus, Tokyo, Japan). Apolipoprotein A-1 (apoA1) and apolipoprotein B-100 (apoB) were measured by their respective commercially available kits using an Olympus autoanalyzer (AU600; Mitsubishi Chemicals, Tokyo, Japan). Low-density lipoprotein (LDL) cholesterol was calculated using Friedwald's formula 23) . Small dense LDL was measured by a precipitation method 24) . Free fatty acid (FFA) was measured using enzymatic colorimetric methods (Wako, Tokyo, Japan). Remnant-like particle (RLP) cholesterol was measured by an immunoaffinity separation method (RLP-C assay; Otsuka, Japan). Preheparin serum lipoprotein lipase (LPL) mass was measured by sandwich ELISA using a specific monoclonal antibody against bovine milk LPL, as described by Kobayashi et al. 25) . Using a commercial kit from Daiichi Pure Chemicals (Tokyo, Japan, interassay CV 2.8%) was used.
Adipokines, Inflammation and Oxidative Stress Markers
Adiponectin was assayed by a sandwich enzymelinked immunosorbent assay (Otsuka Pharmaceutical Co., Ltd., Tokushima City, Japan). Intra-and interassay CV were 3.3% and 7.5%, respectively. Leptin was assessed by an RIA kit from LINCO research (St. Charles, MO, interassay CV 4.9%). Highly sensitive C-reactive protein (hs-CRP) was measured by an immunoturbidometric assay using reagents and calibrators from Dade Behring Marburg GmbH (Marburg, Germany; interassay CV 5%). TNF-was measured by immunoassays (R&D Systems, Inc., Minneapolis, MN, interassay CV 6%). Plasminogen activator inhibitor-1 (PAI-1) was measured by ELISA (Mitsubishi Chemicals, interassay CV 8%). For statistical analysis, serum concentrations of hs-CRP and TNF-below the limit of detection were assigned a value of 0.05 mg/L and 0.50 pg/mL (lowest limit of detection), respectively. Adipokines and inflammatory markers were measured in fasted blood samples.
Statistics
Data are presented as the mean SD unless otherwise stated. Due to deviations from normal distribution, CRP was logarithmically transformed for analysis. Mean differences across tertiles were compared by the nonparametric Mann-Whitney U test. Bivariate correlations of regional fat mass with cardiometabolic parameters were evaluated by both Pearson and Spearman correlation analysis. The two methods gave practically identical results, thus only Pearson correlation coefficients are presented. A two-tailed value of p 0.05 was considered significant. Statistical analysis was performed with SPSS system 17.0 (SPSS Inc., Chicago, IL).
Results
Participants were lean, normoglycemic, normolipidemic and normotensive and had normal liver function tests (Tables 1 and 2). After adjusting for TFM (Table 2) , LFM was positively associated with HDL cholesterol, adiponectin, pre-heparin LPL and insulin sensitivity, as estimated by the Matsuda index, whereas it was negatively related to triglycerides, apolipoprotein B, small dense LDL, FFA, glucose and insulin concentrations at 2h during OGTT, in the AUC of insulin and the white blood cell count. In contrast to LFM, TFM showed opposite associations with all variables described above. TFM was also positively associated with fasting insulin, HOMA-IR, RLP-cholesterol, PAI-1 and log(CRP). LFM was negatively associated with glucose AUC and TNF-.
Participants were divided into 9 groups according to tertiles of TFM and LFM. In the middle tertile of TFM (TMF range: 5.64-7.33 kg), women with LFM in the top tertile had very small but significantly greater TFM than women in low and median tertiles (Table 3A) . Similarly, in the middle tertile of LFM (LMF range: 4.87-5.99 kg), women with TFM in the middle and top tertiles had small but significantly greater TFM than women in the low tertile (Table 3B) .
After adjusting for TFM (Fig. 1) , increases in LFM were associated with stepwise increases in HDL cholesterol (73 2.2, 77 1.5, 80 2.1 mg/dL) and adiponectin (9.2 0.7, 11.6 0.5, 14.7 0.7 g/mL) whereas they were accompanied by stepwise decreases in triglycerides (61 4, 57 3, 47 4 mg/dL), the apoB/A1 ratio (043 001 vs. 041 001 and 039 001) and PAI-1 (25.1 2.5, 22.9 1.7, 15.7 2.3 ng/ mL). Gamma-glutamyltranspeptidase levels in middle and high LFM tertiles (13.2 0.5 and 13.2 0.7 units/L, respectively) were lower than in the low LFM tertile (15.0 0.7 units/L). There was no difference in lean tissue mass in any regions measured in the middle tertile of TFM (data not shown).
In the middle tertile of LFM (LFM range: 4.87-5.99 kg), women with TFM in median and top tertiles had small but significantly greater LFM than women in the low tertile (Table 3B) . After adjusting for LFM (Fig. 2) , young women in the top TFM tertile had greater triglycerides (63 4 vs. 52 4 and 57 3 mg/dL), apo B (72 2 vs. 67 2 and 68 1 mg/ dL), apoB/A1 ratio (045 002 vs. 041 001 and 041 001) and TNF-(0.84 0.10 vs. 0.60 0.05 and 0.60 0.03 ng/mL) than the other 2 groups. RLPcholesterol levels were higher in the middle and high than low TFM tertiles (3.0 0.2 and 3.0 0.1 vs. 2.6 0.2 mg/dL). In contrast, increases in TFM were associated with a stepwise decrease in adiponectin (12.8 0.70, 11.7 0.43, 9.7 0.50 g/mL, Fig. 2) .
Only serum leptin showed positive associations with both TFM and LFM but the association was stronger with TFM than with LFM in young slim women ( Table 2) . Serum leptin increased in a stepwise fashion as LFM (7.0 0.4, 7.2 0.3, 8.6 0.4 ng/ mL) and TFM (6.4 0.3, 7.2 0.3, 9.3 0.4 ng/mL) increased in the middle tertile of TFM and LFM, respectively.
Discussion
The main finding of this study is that even in healthy, slim women in early adult life, larger LFM was associated with a favorable lipid profile, whereas larger TFM was associated with an unfavorable lipid profile. Furthermore, larger LFM was associated with a favorable serum adipokine profile, whereas larger 
Mean SD. n 481 TFM was associated with an unfavorable serum adipokine profile. It is worth noting that in the present study these observations were found in a homogeneous sample of very young female college students, most of whom were nonobese, normolipidemic, nondiabetic, and normotensive. In addition, no subject reported a smoking habit or alcohol intake and no subject was receiving any medications.
There are some known regional differences in adipokine secretion between abdominal subcutaneous and visceral fat 26, 27) , but less is known about differences between gluteal and abdominal subcutaneous fat 28) . Although several studies have reported the protective effects of lower-body fat on lipid metabolism [See Ref. 28] , and a few studies have examined the associations of lower body fat with serum adiponectin as far as we know, no study has examined the associations with serum PAI-1 or TNF-.
In the present study employing young, slim women, larger LFM resulted in increased serum adiponectin. Several other studies with direct measurement of different fat depots by DXA found a positive association of adiponectin with LFM 17, 18) . Furthermore, larger LFM was associated with decreased PAI-1 and lower GGT in addition to higher adiponectin in young, healthy, slim women. Plasma PAI-1 levels have been shown to be more strongly related to liver steatosis than to adipose tissue accumulation 29) although abdominal adipose tissue is an important source of plasma PAI-1 in insulin resistance syndrome with cen- tral obesity 30) . Lower concentrations of hepatic enzymes, including GGT levels 31) , and higher adiponectin 32) appear to reflect lower liver fat content. Taken together, we speculate that liver fat may be a knot linking higher adiponectin, lower PAI-1 and GGT associated with larger LFM found in young women. A negative association between adiponectin and central fat mass accumulation and visceral fat mass 33, 34) was confirmed in the present study. Finally and unexpectedly, we found that larger TFM was associated with higher serum TNF-even in young, healthy, slim women in the present study. We have no explanation for this finding because it is reported that there is no association between body fat distribution and serum TNF-levels 35, 36) , although they were increased in obesity 37, 38) . In addition to favorable effects on the adipokine profile, for a given level of TFM, larger LFM was associated with an advantageous serum lipid profile, i.e., higher HDL cholesterol and lower TG in young healthy, slim women. A favorable association of lower body fat with HDL cholesterol and TG has been reported in postmenopausal women 11, 12) and men 18) . Both serum adiponectin and insulin sensitivity have a mediating role between body fat distribution and blood lipids that may be manifested both in the liver and peripheral tissue 18) . LFM was positively associated with adiponectin in the current study although it was not associated with HOMA-IR, a crude marker of insulin resistance, in young women. Another explanation for favorable effects on the lipid profile is the opposite contributions of regional fat mass to plasma lipase activities 39) . Larger LFM and lower TFM in postmenopausal women were reported to be associated with higher lipoprotein lipase and lower hepatic lipase activities in post-heparin plasma 39) , respectively, both of which contribute to higher HDL cholesterol and lower triglyceride 40) . In the present study, preheparin LPL was associated positively with LFM and negatively with TFM in young women, although most pre-heparin LPL is in an inactive form but might reflect somewhat the amount of LPL working in the body 41) . There was, however, no difference in pre-heparin LPL mass among the tertiles of both LFM and TFM in the current study.
Abnormal apolipoprotein B metabolism has been reported to occur in the early phase of normoglycemic and fasting normotriglyceridemic insulin-resistant women with abdominal obesity 42) . This may be consistent with our finding that larger TFM was associated with an increase in apolipoprotein B in young, slim women. In addition, elevated concentrations of RLP-cholesterol and triglycerides as well as apolipoprotein B, all of which were associated with larger TFM in young women in the present study, have been shown to be a characteristic feature of the atherogenic lipoprotein phenotype 42, 43) . Finally, larger TFM was associated with a greater ratio of apo B to A1, a strong, new risk factor for cardiovascular disease 44) , in young women in the present study.
The main limitation of our study is that DXA does not allow separate quantification of intermuscular and subcutaneous fat in the legs, and visceral fat and subcutaneous fat in the trunk. The contribution of subcutaneous fat to the total amount of fat in the legs, however, is relatively large 45) ; therefore, the associations found in our study with fat mass in the legs are probably mainly due to the subcutaneous fat depot. The cross-sectional design of the present study complicates the drawing of causal inferences, and a single measurement of biochemical variables may be susceptible to short-term variation, which would bias the results toward the null. We used several surrogates in the present study, which may be less accurate.
In summary, larger fat mass in the lower body has a considerable and favorable association with lipoprotein and adipokine metabolism even in healthy, slim, young women. These findings provide relevant new insight into the associations among obesity, body composition, and type 2 diabetes. Further investigation of the underlying pathophysiological mechanism is needed to explain the favorable association of leg fat with lipoprotein and adipokine metabolism. Table 3 . Data are the mean SE. Means not sharing common letters are significantly different at p 0.05 or less. TNF-: tumor necrosis factor-, RLP-cholesterol: remnant-like particle cholesterol, ApoB: apolipoprotein B.
